Everard, A
PMID: Summary Keywords GLP-1 receptor (GLP-1R), metabolic dysfunction, Mitochondria-ER Contact Sites (MERCS), signalosomes, GLP1 receptor agonist (GLP1-RAs) Citation Cruz P, Puebla-Huerta A, Troncoso MF, Silva-Pavez E, Hidalgo-Fadic Y and Ahumada-Castro U (2026) GLP-1 receptor and Mitochondria-ER Contact Sites: an emerging mechanism of metabolic regulation
Additionally, it assists with restoring metabolic balance and likely encourages beneficial effects of tesamorelin, such as more localized reduction of fat and a normal or better energy balance, all while not exposing the person to elevated or excess hormones beyond safer levels regulated physiologically
Quality and regulation managers should be aware that both drugs need to be closely watched during clinical use, and there are clear plans for dealing with side effects by changing the amount
In those on maximal dose of a GLP-1 RA (either subcutaneous or oral), I would initiate tirzepatide at the 5 mg weekly dose